院内感染対策の市場規模、シェア、成長分析：製品別、用途別、技術別、疾患別、エンドユーザー別、地域別 - 産業予測 2025～2032年

院内感染対策の2023年の市場規模は304億米ドルで、予測期間（2025～2032年）のCAGRは7.3%で、2024年の326億2,000万米ドルから2032年には573億2,000万米ドルに成長する見通しです。

院内感染（HAI）市場は、いくつかの重要な促進要因によって力強い成長を遂げています。交差感染を減らす必要性に対する意識の高まりと、ヘルスケア環境における感染症の流行がこの動向の中心となっています。感染予防対策の強化を提唱する政府の積極的な取り組みが、市場の拡大をさらに加速させています。病院、地域、国レベルで厳格な感染防止基準が実施されることで、医療環境における安全と衛生の文化が醸成されます。さらに、モニタリングソリューションの採用が増加していることは極めて重要であり、医療提供者がHAIを効果的に予防・管理するための積極的な手段を講じることができるため、患者の安全性と健康アウトカムの改善に対する全体的な取り組みが強化されることになります。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

院内感染対策市場規模：製品とサービス別

• 市場概要
• 保護バリア
• 殺菌
• 消毒剤
  • 製品
  • 手指消毒剤
  • 表面消毒剤
  • 皮膚消毒剤
  • 器具消毒剤
  • 製剤
  • 液体消毒剤
  • 消毒用ワイプ
  • 消毒スプレー
• 消毒剤
• 内視鏡再処理製品
• その他の感染管理製品

院内感染対策市場規模：用途別

• 市場概要
• 病気の検査
• 薬剤耐性検査

院内感染対策市場規模：技術別

• 市場概要
• 表現型分析法
• 遺伝子型法

院内感染対策市場規模：疾患別

• 市場概要
• 院内肺炎
• 血流感染症
• 手術部位感染症
• 胃腸感染症
• 尿路感染症
• その他

院内感染対策市場規模：エンドユーザー別

• 市場概要
• 病院とICU
• 外来手術と診断センター
• 介護施設と産科センター
• その他

院内感染対策市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• 3M Company（United States）
• Becton, Dickinson and Company（BD）（United States）
• bioMerieux SA（France）
• Ecolab Inc.（United States）
• Getinge AB（Sweden）
• Advanced Sterilization Products（ASP）（United States）
• Belimed AG（Switzerland）
• Matachana Group（Spain）
• MMM Group（Germany）
• Reckitt Benckiser Group plc（United Kingdom）
• Metrex Research LLC（United States）
• Miele Group（Germany）
• Pal International（United Kingdom）
• Melag Medizintechnik GmbH & Co. KG（Germany）
• Contec, Inc.（United States）
• MEDALKAN（Greece）
• Systec GmbH（Germany）
• C.B.M. S.r.l. Medical Equipment（Italy）
• Continental Equipment Company（United States）
• BGS Beta-Gamma-Service GmbH & Co. KG（Germany）

結論と提言

Hospital-Acquired Infection Control Market size was valued at USD 30.4 billion in 2023 and is poised to grow from USD 32.62 billion in 2024 to USD 57.32 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032).

The Hospital Acquired Infections (HAIs) market is experiencing robust growth due to several critical drivers. An increased awareness of the need to reduce cross infections and the ongoing prevalence of infectious diseases in healthcare settings are central to this trend. Supportive government initiatives that advocate for enhanced infection control practices further amplify market expansion. The implementation of stringent infection prevention standards at hospital, regional, and national levels fosters a culture of safety and hygiene within medical environments. Additionally, the rising adoption of monitoring solutions is pivotal, as it empowers healthcare providers to take proactive steps in effectively preventing and managing HAIs, thereby reinforcing the overall commitment to improving patient safety and health outcomes.

Top-down and bottom-up approaches were used to estimate and validate the size of the Hospital-Acquired Infection Control market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Hospital-Acquired Infection Control Market Segments Analysis

Global Hospital-Acquired Infection Control Market is segmented by Product, Application, Technology, Disease, End User and region. Based on Product, the market is segmented into Protective Barrier, Sterilization, Disinfectants, Disinfectors, Endoscope Reprocessing Products and Other Infection Control Products. Based on Application, the market is segmented into Disease Testing and Drug-Resistance Testing. Based on Technology, the market is segmented into Phenotypic Methods and Genotypic Methods. Based on Disease, the market is segmented into Hospital Acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infection and Others. Based on End User, the market is segmented into Hospitals & ICUs, Ambulatory Surgical & Diagnostic Centers, Nursing Homes & Maternity Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market is significantly driven by the notable increase in the number of surgical procedures performed globally in recent years. According to the World Health Organization's 2022 data, approximately 330 million major surgeries are conducted each year around the world. This surge can be attributed to various factors, including the rising incidence of obesity and other lifestyle-related health conditions, which often require surgical solutions for effective treatment and management. As more surgeries are performed, the demand for robust infection control measures in hospitals continues to escalate, underscoring the importance of enhancing patient safety and care standards.

Restraints in the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market faces significant restraints primarily because healthcare providers frequently choose to reprocess reusable medical devices to save costs and minimize waste. These devices include various instruments, such as surgical forceps, endoscopes, and stethoscopes. However, this practice raises ongoing concerns about the safety and effectiveness of these reprocessed instruments. As the apprehension surrounding potential risks to patient safety continues to grow, it complicates the market dynamics for infection control solutions, as both healthcare facilities and patients prioritize safer alternatives to ensure better health outcomes and reduce the incidence of hospital-acquired infections.

Market Trends of the Hospital-Acquired Infection Control Market

The Hospital-Acquired Infection Control market is witnessing a significant trend with the reintroduction of ethylene oxide sterilization, a key method known for its efficiency in sterilizing temperature-sensitive medical instruments. This resurgence is driven by the increasing demand for effective sterilization methods amid rising hospital-acquired infections, combined with a push for improved infection control protocols. However, the market is also experiencing scrutiny over potential health risks associated with ethylene oxide exposure, prompting regulatory bodies to assess safety standards. As hospitals seek to balance efficacy and safety, advancements in ethylene oxide technology and alternative sterilization methods are anticipated to shape the future dynamics of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Hospital-Acquired Infection Control Market Size by Product & Services & CAGR (2025-2032)

• Market Overview
• Protective Barrier
• Sterilization
• Disinfectants
  • Product
  • Hand Disinfectants
  • Surface Disinfectants
  • Skin Disinfectants
  • Instrument Disinfectants
  • Formulation
  • Liquid Disinfectants
  • Disinfectant Wipes
  • Disinfectant Sprays
• Disinfectors
• Endoscope Reprocessing Products
• Other Infection Control Products

Global Hospital-Acquired Infection Control Market Size by Application & CAGR (2025-2032)

• Market Overview
• Disease Testing
• Drug-Resistance Testing

Global Hospital-Acquired Infection Control Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Phenotypic Methods
• Genotypic Methods

Global Hospital-Acquired Infection Control Market Size by Disease & CAGR (2025-2032)

• Market Overview
• Hospital Acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infection
• Others

Global Hospital-Acquired Infection Control Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & ICUs
• Ambulatory Surgical & Diagnostic Centers
• Nursing Homes & Maternity Centers
• Others

Global Hospital-Acquired Infection Control Market Size & CAGR (2025-2032)

• North America (Product & Services, Application, Technology, Disease, End User)
  • US
  • Canada
• Europe (Product & Services, Application, Technology, Disease, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Services, Application, Technology, Disease, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Services, Application, Technology, Disease, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Services, Application, Technology, Disease, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• 3M Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ecolab Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Sterilization Products (ASP) (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Belimed AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Matachana Group (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MMM Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metrex Research LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miele Group (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pal International (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melag Medizintechnik GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contec, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MEDALKAN (Greece)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Systec GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• C.B.M. S.r.l. Medical Equipment (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Continental Equipment Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGS Beta-Gamma-Service GmbH & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations